HCA Healthcare (NYSE:HCA) Releases Earnings Results, Beats Expectations By $0.19 EPS

HCA Healthcare (NYSE:HCA) released its quarterly earnings results on Friday. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19, RTT News reports. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same quarter last year, the business earned $5.90 EPS. HCA Healthcare updated its FY 2025 guidance to 24.050-25.850 EPS.

HCA Healthcare Trading Down 4.0 %

Shares of HCA stock opened at $312.51 on Friday. The stock has a 50-day moving average of $313.49 and a 200-day moving average of $352.62. HCA Healthcare has a 1-year low of $279.93 and a 1-year high of $417.14. The stock has a market cap of $79.16 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 1.09 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HCA. Morgan Stanley cut their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, TD Cowen reduced their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.